JP2003501110A5 - - Google Patents

Download PDF

Info

Publication number
JP2003501110A5
JP2003501110A5 JP2001502873A JP2001502873A JP2003501110A5 JP 2003501110 A5 JP2003501110 A5 JP 2003501110A5 JP 2001502873 A JP2001502873 A JP 2001502873A JP 2001502873 A JP2001502873 A JP 2001502873A JP 2003501110 A5 JP2003501110 A5 JP 2003501110A5
Authority
JP
Japan
Prior art keywords
amino acid
acid sequence
vaccine
seq
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001502873A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003501110A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/015925 external-priority patent/WO2000076540A2/en
Publication of JP2003501110A publication Critical patent/JP2003501110A/ja
Publication of JP2003501110A5 publication Critical patent/JP2003501110A5/ja
Pending legal-status Critical Current

Links

JP2001502873A 1999-06-10 2000-06-09 肺炎連鎖球菌タンパク質とワクチン Pending JP2003501110A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13845399P 1999-06-10 1999-06-10
US60/138,453 1999-06-10
PCT/US2000/015925 WO2000076540A2 (en) 1999-06-10 2000-06-09 Streptococcus pneumoniae proteins and vaccines

Publications (2)

Publication Number Publication Date
JP2003501110A JP2003501110A (ja) 2003-01-14
JP2003501110A5 true JP2003501110A5 (cg-RX-API-DMAC7.html) 2007-08-16

Family

ID=22482080

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001502873A Pending JP2003501110A (ja) 1999-06-10 2000-06-09 肺炎連鎖球菌タンパク質とワクチン

Country Status (9)

Country Link
EP (2) EP1185297B1 (cg-RX-API-DMAC7.html)
JP (1) JP2003501110A (cg-RX-API-DMAC7.html)
AT (2) ATE325620T1 (cg-RX-API-DMAC7.html)
AU (1) AU777856B2 (cg-RX-API-DMAC7.html)
CA (1) CA2371714C (cg-RX-API-DMAC7.html)
DE (2) DE60045721D1 (cg-RX-API-DMAC7.html)
ES (2) ES2264419T3 (cg-RX-API-DMAC7.html)
HK (1) HK1043943A1 (cg-RX-API-DMAC7.html)
WO (1) WO2000076540A2 (cg-RX-API-DMAC7.html)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7135560B1 (en) 1997-07-02 2006-11-14 Sanofi Pasteur Limited Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
US6800744B1 (en) 1997-07-02 2004-10-05 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
US7128918B1 (en) 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
US7074415B2 (en) 2000-06-20 2006-07-11 Id Biomedical Corporation Streptococcus antigens
GB0022742D0 (en) 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
AU2002351623A1 (en) 2001-12-20 2003-07-09 Shire Biochem Inc. Streptococcus antigens
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
ES2707499T3 (es) 2005-12-22 2019-04-03 Glaxosmithkline Biologicals Sa Vacuna de conjugado de polisacárido neumocócico
EA201391788A1 (ru) 2007-06-26 2014-08-29 Глаксосмитклайн Байолоджикалс С.А. Вакцина, содержащая конъюгаты капсульных полисахаридов streptococcus pneumoniae
GB0714963D0 (en) 2007-08-01 2007-09-12 Novartis Ag Compositions comprising antigens
AU2008336295B2 (en) * 2007-12-13 2013-07-11 Intervacc Ab Improved immunizing composition
KR101208778B1 (ko) 2008-03-03 2012-12-05 노파르티스 아게 Tlr 활성 조정제로서의 화합물 및 조성물
HUE026586T2 (hu) 2008-04-16 2016-06-28 Glaxosmithkline Biologicals Sa Vakcina
WO2010144734A1 (en) 2009-06-10 2010-12-16 Novartis Ag Benzonaphthyridine-containing vaccines
AU2010273708B2 (en) 2009-06-29 2015-10-01 Children's Medical Center Corporation Vaccines and compositions against Streptococcus pneumoniae
CN102844047B (zh) 2009-09-02 2017-04-05 诺华股份有限公司 含tlr活性调节剂的免疫原性组合物
JO3257B1 (ar) 2009-09-02 2018-09-16 Novartis Ag مركبات وتركيبات كمعدلات لفاعلية tlr
BR112012008338A2 (pt) 2009-09-10 2019-09-24 Novartis Ag combinação de vacinas contra doenças do trato respiratório.
WO2011057148A1 (en) 2009-11-05 2011-05-12 Irm Llc Compounds and compositions as tlr-7 activity modulators
CN102762206A (zh) 2009-12-15 2012-10-31 诺华有限公司 免疫增强化合物的均匀悬液及其用途
GB201003924D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Immunogenic composition
CA2792938C (en) 2010-03-23 2018-07-31 Irm Llc Compounds (cystein based lipopeptides) and compositions as tlr2 agonists used for treating infections, inflammations, respiratory diseases etc.
WO2012072769A1 (en) 2010-12-01 2012-06-07 Novartis Ag Pneumococcal rrgb epitopes and clade combinations
MY163871A (en) 2011-01-20 2017-10-31 Genocea Biosciences Inc Vaccines and compositions against streptococcus pneumoniae
CA2834834A1 (en) 2011-05-17 2012-11-22 Glaxosmithkline Biologicals S.A. Vaccine against streptococcus pneumoniae
US20150132339A1 (en) 2012-03-07 2015-05-14 Novartis Ag Adjuvanted formulations of streptococcus pneumoniae antigens
CN105188747A (zh) 2013-02-01 2015-12-23 葛兰素史密斯克莱生物公司 包含toll样受体激动剂的免疫组合物的皮内递送
DK3752182T3 (da) 2018-02-12 2024-08-12 Inimmune Corp Toll-like receptor ligands
EP4240843A1 (en) 2020-11-04 2023-09-13 Eligo Bioscience Cutibacterium acnes recombinant phages, method of production and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69739981D1 (de) * 1996-10-31 2010-10-14 Human Genome Sciences Inc Streptococcus pneumoniae-Antigene und Impfstoffe
EP1144640A3 (en) * 1998-07-27 2001-11-28 Microbial Technics Limited Nucleic acids and proteins from streptococcus pneumoniae

Similar Documents

Publication Publication Date Title
JP2003501110A5 (cg-RX-API-DMAC7.html)
CA2371714A1 (en) Streptococcus pneumoniae proteins and vaccines
JP2003515323A5 (cg-RX-API-DMAC7.html)
JP2006525330A5 (cg-RX-API-DMAC7.html)
CN1610697A (zh) 戊型肝炎病毒单克隆抗体或其结合活性片段及其用途
RU2006127314A (ru) Вакцина, стимулирующая рост, основанная на нейтрализующем эпитопе
UA40621C2 (uk) Моноклональне антитіло, гібридомна клітинна лінія, поліпептид (варіанти), фрагмент днк (варіанти), фармацевтична композиція, спосіб одержання моноклонального антитіла
JP2004517611A5 (cg-RX-API-DMAC7.html)
JP2002505843A5 (cg-RX-API-DMAC7.html)
CA2674885A1 (en) Anti-ige vaccines
EP2292646A3 (en) Small Streptococcus pyogenes antigens and their use
JP2003530872A5 (cg-RX-API-DMAC7.html)
NO20011381L (no) Preparater av streptokokk C<beta>-protein
IL127595A0 (en) Polypeptides capable of forming antigen binding structures with specificity for the rhesus D antigens the DNA encoding them and the process for their preparation and use
JP2002534481A5 (cg-RX-API-DMAC7.html)
JP2003531634A5 (cg-RX-API-DMAC7.html)
AU702294B2 (en) Proteins from mammalian liver and their use in oncology
EP1546357B1 (en) Immunogenic mycoplasma hyopneumoniae polypeptides
DK200601181A (da) Fiskevaccine
CA2411949A1 (en) Cryptosporidium parvum antigens, antibodies thereto and diagnostic and therapeutic compositions thereof
CA2967778A1 (en) Anti-thyroglobulin t cell receptors
IL125645A0 (en) Recombinant phages
KR970070198A (ko) 항-파스 재조합 항체 및 이에 대한 디엔아이
CA2411919A1 (en) Immunization of dairy cattle with chimeric gapc protein against streptococcus infection
CA2475821A1 (en) Group b streptococcus antigens